• 1
    Arita Y, Kihara S, Ouchi N et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105: 28932898.
  • 2
    Pollin TI, Tanner K, O'Connell JR et al. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes 2005; 54: 268274.
  • 3
    Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 15951599.
  • 4
    Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 19301935.
  • 5
    Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 24732476.
  • 6
    Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 7983.
  • 7
    Fruebis J, Tsao TS, Javorschi S et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 20052010.
  • 8
    Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941946.
  • 9
    Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7: 947953.
  • 10
    Chuang LM, Chiu YF, Sheu WH et al. Biethnic comparisons of autosomal genomic scan for loci linked to plasma adiponectin in populations of Chinese and Japanese origin. J Clin Endocrinol Metab 2004; 89: 57725778.
  • 11
    Guerre-Millo M. Adipose tissue hormones. J Endocrinol Invest 2002; 25: 855861.
  • 12
    Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond. Horm Metab Res 2002; 34: 469474.
  • 13
    Haluzik M, Parizkova J, Haluzik MM. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 2004; 53: 123129.
  • 14
    Maeda N, Takahashi M, Funahashi T et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50: 20942099.
  • 15
    Yang WS, Tsou PL, Lee WJ et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med 2003; 81: 428434.
  • 16
    Lindsay RS, Funahashi T, Krakoff J et al. Genome-wide linkage analysis of serum adiponectin in the Pima Indian population. Diabetes 2003; 52: 24192425.
  • 17
    Comuzzie AG, Funahashi T, Sonnenberg G et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001; 86: 43214325.
  • 18
    Guo X, Saad MF, Langefeld CD et al. Genome-wide linkage of plasma adiponectin reveals a major locus on chromosome 3q distinct from the adiponectin structural gene: the IRAS Family Study. Diabetes 2006; 55: 17231730.
  • 19
    Tejero ME, Cai G, Goring HH et al. Linkage analysis of circulating levels of adiponectin in Hispanic children. Int J Obes (Lond) 2007; 31: 535542.
  • 20
    Stirnadel H, Lin X, Ling H et al. Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: The GEMS Study. Atherosclerosis 2008; 197: 868876.
  • 21
    Wyszynski DF, Waterworth DM, Barter PJ et al. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol 2005; 95: 194198.
  • 22
    Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 11981211.
  • 23
    Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263265.
  • 24
    Hug C, Wang J, Ahmad NS et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 2004; 101: 1030810313.
  • 25
    Damcott CM, Ott SH, Pollin TI et al. Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish. Diabetes 2005; 54: 22452250.
  • 26
    Fumeron F, Aubert R, Siddiq A et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004; 53: 11501157.
  • 27
    Heid IM, Wagner SA, Gohlke H et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006; 55: 375384.
  • 28
    Hara K, Boutin P, Mori Y et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536540.
  • 29
    Bouatia-Naji N, Meyre D, Lobbens S et al. ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 2006; 55: 545550.
  • 30
    Sutton BS, Weinert S, Langefeld CD et al. Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study. Hum Genet 2005; 117: 107118.
  • 31
    Kissebah AH, Sonnenberg GE, Myklebust J et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 2000; 97: 1447814483.
  • 32
    Vasseur F, Helbecque N, Dina C et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11: 26072614.
  • 33
    Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87: 27642769.
  • 34
    Takeuchi T, Adachi Y, Ohtsuki Y, Furihata M. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 2007; 40: 115120.
  • 35
    Adeyemo A, Luke A, Cooper R et al. A genome-wide scan for body mass index among Nigerian families. Obes Res 2003; 11: 266273.
  • 36
    Atwood LD, Heard-Costa NL, Cupples LA et al. Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study. Am J Hum Genet 2002; 71: 10441050.
  • 37
    Johnson L, Luke A, Adeyemo A et al. Meta-analysis of five genome-wide linkage studies for body mass index reveals significant evidence for linkage to chromosome 8p. Int J Obes (Lond) 2005; 29: 413419.
  • 38
    Hanyu O, Miida T, Obayashi K et al. Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity. Atherosclerosis 2004; 174: 385390.
  • 39
    Miyashita Y, Shirai K, Itoh Y et al. Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy. Diabetes Res Clin Pract 2002; 56: 181187.
  • 40
    Miyashita Y, Shirai K. Clinical determination of the severity of metabolic syndrome: preheparin lipoprotein lipase mass as a new marker of metabolic syndrome. Curr Med Chem Cardiovasc Hematol Agents 2005; 3: 377381.
  • 41
    Saiki A, Oyama T, Endo K et al. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. Diabetes Res Clin Pract 2007; 76: 93101.
  • 42
    Kobayashi J, Kusunoki M, Murase Y et al. Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men. Horm Metab Res 2005; 37: 505509.
  • 43
    Barter P, Gotto AM, LaRosa JC et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007; 357: 13011310.
  • 44
    Berra M, Armillotta F, D'Emidio L et al. Testosterone decreases adiponectin levels in female to male transsexuals. Asian J Androl 2006; 8: 725729.
  • 45
    Xu A, Chan KW, Hoo RL et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005; 280: 1807318080.
  • 46
    Baratta R, Amato S, Degano C et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 2004; 89: 26652671.